NCT01106092View on ClinicalTrials.gov

Study to Evaluate the Immunogenicity and Reactogenicity of a Booster Dose of GSK2036874A Vaccine in Healthy Toddlers

PHASE2CompletedINTERVENTIONAL
Enrollment

312

Participants

Timeline

Start Date

May 13, 2010

Primary Completion Date

September 2, 2010

Study Completion Date

September 2, 2010

Conditions
Haemophilus Influenzae Type bTetanusHepatitis BWhole Cell PertussisDiphtheriaPoliomyelitis Vaccines
Interventions
BIOLOGICAL

GSK2036874A vaccine

Intramuscular, single dose

BIOLOGICAL

Zilbrix™/Hib vaccine

Intramuscular, single dose

BIOLOGICAL

Poliorix™

Intramuscular, single dose

Trial Locations (1)

1781

GSK Investigational Site, City of Muntinlupa

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY